Long-term efficacy and safety of once-monthly pasireotide in patients with Cushing's disease: A Phase III extension study
暂无分享,去创建一个
M. Fleseriu | M. Roughton | J. Newell-Price | G. T’Sjoen | A. Lacroix | B. Biller | M. Vantyghem | S. Ravichandran | L. Tauchmanovà | P. Kadıoğlu | S. Petersenn | B. C. De